New eye injection aims to clear corneal swelling
NCT ID NCT05636579
First seen Jan 05, 2026 · Last updated May 13, 2026 · Updated 25 times
Summary
This early-stage study tests the safety of an experimental drug called EO2002, given as an injection into the eye, for people with corneal edema (swelling of the clear front part of the eye). The study involves 12 adults with corneal swelling caused by Fuchs' dystrophy or after cataract surgery. Some participants will also receive a topical eye drop called ripasudil. The main goal is to see if the treatment is safe and tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOTHELIAL DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asociacion para Evitar la Ceguera en Mexico
RECRUITINGMexico City, Mexico City, 04030, Mexico
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.